Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

857
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

788
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
788
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

707
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
707
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parametric hypothesis testing for pathway based hierarchical structural component models.

Genes & genomics·2026
Same author

Analysis of severity in COVID-19 patients by using longitudinal immune profiles.

iScience·2026
Same author

Enhancing polygenic risk prediction by modeling quantile-specific genetic effects.

Scientific reports·2026
Same author

Optoelectronic Synaptic Transistors Based on Colloidal CdSe Nanowires for Energy-Efficient Neuromorphic Computing.

ACS applied materials & interfaces·2026
Same author

Complex analyticity of the nonlinear Poisson-Boltzmann equation for the interface problem with random domains.

Numerische mathematik·2026
Same author

Analytic regularity of strong solutions for the complexified stochastic nonlinear Poisson-Boltzmann Equation.

Computers & mathematics with applications (Oxford, England : 1987)·2026
Same journal

Real-time EEG-based epileptic seizure prediction using artificial intelligence: A systematic review.

Artificial intelligence in medicine·2026
Same journal

R-peak detection and ECG data compression scheme based on empirical mode decomposition and wavelet transform.

Artificial intelligence in medicine·2026
Same journal

CastNet: A three-channel EEG-based deep learning model for cross-subject depression detection.

Artificial intelligence in medicine·2026
Same journal

State-of-the-art TinyML approaches for colorectal cancer detection: Current advances, challenges, and future directions.

Artificial intelligence in medicine·2026
Same journal

JRadiEvo: A Japanese radiology report generation model enhanced by evolutionary optimization of model merging.

Artificial intelligence in medicine·2026
Same journal

Causally-informed deep learning towards explainable and generalizable outcome prediction in critical care.

Artificial intelligence in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

879

Cancer survival classification using integrated data sets and intermediate information.

Shinuk Kim1, Taesung Park2, Mark Kon3

  • 1College of Liberal Arts, Sangmyung University, 31 Sangmyungdae-gil, Cheonan, Chungnam 330-729, Republic of Korea; Department of Statistics, Seoul National University, 1 Gwankak-ro, Seoul 151-747, Republic of Korea; Department of Mathematics and Statistics, Boston University, 111 Cummington Mall, Boston, MA 02215, USA.

Artificial Intelligence in Medicine
|July 7, 2014
PubMed
Summary
This summary is machine-generated.

Integrating microRNA (miRNA) and mRNA expression data improves cancer survival prediction accuracy. A novel machine learning approach, FSCOX-SVM, utilizing feature selection with Cox proportional hazard regression, achieved the highest accuracy by leveraging intermediate survival information.

Keywords:
Integration of data setsIntermediate informationMachine learning algorithmSurvival time classification

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

879
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics
  • Cancer Research

Background:

  • Accurate prediction of cancer survival remains a significant challenge in oncology.
  • Integrating diverse biological data, such as microRNA (miRNA) and messenger RNA (mRNA) expression profiles, holds promise for enhancing predictive models.
  • Existing machine learning (ML) methods often overlook valuable intermediate survival information.

Purpose of the Study:

  • To develop and evaluate a novel machine learning approach for improving cancer survival prediction accuracy.
  • To integrate miRNA and mRNA expression data for more robust survival classification.
  • To leverage intermediate survival information typically discarded in binary survival classifications.

Main Methods:

  • A machine learning-based protocol was employed for feature selection, integrating miRNA and mRNA expression profiles at the feature level.
  • A novel feature selection with Cox proportional hazard regression model (FSCOX) was developed to utilize intermediate survival information.
  • Classifiers including Support Vector Machine (SVM), Random Forest (RF), FSCOX-median, and FSCOX-SVM were compared using ovarian and glioblastoma multiforme cancer datasets.

Main Results:

  • The integrated miRNA and mRNA expression data consistently yielded higher survival classification accuracy compared to individual data sets across all tested methods.
  • The FSCOX-SVM method, utilizing independent feature selection (IFS) on combined data, achieved the highest accuracy (88.64% in ovarian cancer).
  • The study identified potential interactions between miRNA and mRNA features crucial for survival prediction, not evident in single-data analyses.

Conclusions:

  • Integration of miRNA and mRNA expression data significantly enhances cancer survival prediction accuracy.
  • The FSCOX-SVM method, incorporating intermediate survival data and combined feature sets, demonstrates superior performance.
  • The findings highlight the importance of multi-modal data integration and advanced feature selection techniques for improved cancer prognosis.